Fresenius Medical Care uses cookies on this website to enhance the user experience and provide the best possible service. By continuing to browse the website, you consent to our use of cookies. For details see our privacy policy.
Our company has had an excellent earnings growth and cash flow performance in the past years. Looking forward, we intend to further strengthen our business and enhance total shareholder return.
Michael Brosnan
Chief Financial Officer
On May 20, 2013 we commenced, as announced on May 17, 2013, our share buy-back program on the basis of the authorization by the Annual General Meeting 2011.
In the context of this share buy-back program, ordinary shares of Fresenius Medical Care in the total amount of €385 million (excluding fees) were repurchased in the period from May 20, 2013 until August 14, 2013. Accordingly, the share buy-back program was fully completed on August 14, 2013. The program was financed from cash flow and existing credit facilities.
In the following we inform you about the number of shares acquired in the context of the share buy-back program.
The own shares acquired by the company will be used to serve the sole purposes of either reducing the registered share capital of the company by cancellation of the acquired own shares, or fulfilling employee participation programs of the company.
